Home / Drug shortages / Clindamycin Phosphate Injection

Clindamycin Phosphate Injection — FDA Drug Shortage

Current — Pfizer Inc.

The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Pfizer Inc. with status Current. The shortage was first posted on 03/21/2023. Reported reason: Discontinuation of the manufacture of the drug

Shortage Details

Status
Current
Company
Pfizer Inc.
Package NDC
0009-3051-02
Dosage Form
Injection
Presentation
Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL) (NDC 0009-3051-02)
Initial Posting
03/21/2023
Revised Date

Reason

Discontinuation of the manufacture of the drug

FDA data resources